By Associate Professor Mark Danta

Preprints

Joseph Yeoh YK; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2023, Temporal change in etiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients with hepatocellular carcinoma in New South Wales, Australia, , http://dx.doi.org/10.1101/2023.02.20.23286164

Lockhart I; Yeo MGH; Hajarizadeh B; Dore GJ; Danta M, Hepatocellular Carcinoma Incidence After Hepatitis C Cure Among Patients With Advanced Fibrosis or Cirrhosis: A Systematic Review and Meta-Analysis, , http://dx.doi.org/10.2139/ssrn.3950271

Regina TZH; Lockhart I; Abdel Shaheed C; Danta M, The Effects of Non-Steroidal Anti-Inflammatory Drugs and Anti-Platelet Therapy on the Incidence and Recurrence of Hepatocellular Carcinoma: A Meta-Analysis, , http://dx.doi.org/10.2139/ssrn.3826213

Back to profile page